E-LIB Suche - Ergebnisse für: Takayama, Asuka

1

Factors influencing the prognosis of patients with acute ce..:

Sato, Hirofumi ; Okawa, Shinsuke ; Kakehata, Reina...
Journal of Physical Therapy Science. 36 (2024) 6 - p. 352-358 , 2024

Link: https://doi.org/10.1589/..

2

Efficacy and safety of dose escalation of tofacitinib in re..:

Ida, Tomoaki ; Furuta, Shunsuke ; Takayama, Asuka...
RMD Open. 9 (2023) 1 - p. e002795 , 2023

Link: https://doi.org/10.1136/..

3

Evolution of the alternative AQP2 gene: Acquisition of a no..:

Kishida, Takushi ; Suzuki, Miwa ; Takayama, Asuka
Molecular Phylogenetics and Evolution. 118 (2018) - p. 54-57 , 2018

Link: https://doi.org/10.1016/..

4

Comparison of ancillary ligand effects between 2,2′-bipyrid..:

Takayama, Asuka ; Suzuki, Takayoshi ; Ikeda, Miyu..
Dalton Transactions. 42 (2013) 40 - p. 14556 , 2013

Link: https://doi.org/10.1039/..

5

A Polymorphic Platinum(II) Complex: Yellow, Red, and Green ..:

Nishiuchi, Yuta ; Takayama, Asuka ; Suzuki, Takayoshi.
European Journal of Inorganic Chemistry. 2011 (2011) 11 - p. 1815-1823 , 2011

Link: https://doi.org/10.1002/..

6

Crystal structures of (azido)(pentamethylcyclopentadienyl)i..:

Suzuki, Takayoshi ; Kotera, Mai ; Takayama, Asuka.
Polyhedron. 28 (2009) 11 - p. 2287-2293 , 2009

Link: https://doi.org/10.1016/..

7

Efficacy and safety of dose escalation of tofacitinib in re..:

Ida, Tomoaki ; Furuta, Shunsuke ; Takayama, Asuka...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809321/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Efficacy and safety of dose escalation of tofacitinib in re..:

Kei Ikeda ; Taro Iwamoto ; Shunsuke Furuta...
https://rmdopen.bmj.com/content/9/1/e002795.full. , 2023

Link: https://doi.org/10.1136/..

9

Suppressive Effects of Neuromedin U Receptor 2-Selective Pe..:

Nomoto, Asuka ; Suzuki, Yui ; Morito, Katsuya..
ACS Medicinal Chemistry Letters. 15 (2024) 3 - p. 376-380 , 2024

Link: https://doi.org/10.1021/..

10

Prognostic impact of clinical factors for immune checkpoint..:

Takei, Shota ; Kawachi, Hayato ; Yamada, Tadaaki...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

11

Comparing Three Different Anti–Programmed Death-Ligand 1 An..:

Katayama, Yuki ; Yamada, Tadaaki ; Morimoto, Kenji...
JTO Clinical and Research Reports. 5 (2024) 3 - p. 100644 , 2024

Link: https://doi.org/10.1016/..

12

Efficacy and Safety of Docetaxel plus Ramucirumab for Patie..:

Onoi, Keisuke ; Yamada, Tadaaki ; Morimoto, Kenji...
Targeted Oncology. 19 (2024) 3 - p. 411-421 , 2024

Link: https://doi.org/10.1007/..

13

Correction: UTX inactivation in germinal center B cells pro..:

Rizq, Ola ; Mimura, Naoya ; Oshima, Motohiko...
Leukemia. 37 (2023) 9 - p. 1952-1952 , 2023

Link: https://doi.org/10.1038/..

14

UTX inactivation in germinal center B cells promotes the de..:

Rizq, Ola ; Mimura, Naoya ; Oshima, Motohiko...
Leukemia. 37 (2023) 9 - p. 1895-1907 , 2023

Link: https://doi.org/10.1038/..

15

TTF-1 Expression and Clinical Outcomes of Combined Chemoimm..:

Katayama, Yuki ; Yamada, Tadaaki ; Morimoto, Kenji...
JTO Clinical and Research Reports. 4 (2023) 4 - p. 100494 , 2023

Link: https://doi.org/10.1016/..